55716-28-4, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 55716-28-4, molcular formula is C9H9N3O, introducing its new discovery.
Novartis AG
Novel 8-aryl-1,7-naphthyridines, in free or salt form, are PDE IV inhibitors and are thus useful as pharmaceuticals, e.g. for asthma therapy. Preferred compounds include compounds of formulae (I and II) wherein the R groups are as defined. Pharmaceutical compositions comprising the compounds, processes for preparation of the compounds and novel intermediates for use in the processes are disclosed.
Because enzymes can increase reaction rates by enormous factors and tend to be very specific, 55716-28-4, typically producing only a single product in quantitative yield, they are the focus of active research.you can also check out more blogs about 55716-28-4
Reference£º
1,503-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N497 – PubChem